Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356492 · ClinicalTrials.gov registry record · NA
Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach
A NA study of Health and Connectedness, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 2,700
- Enrollment target
- 1
- Study location
NCT07356492: Recruiting NA study of Health and Connectedness, sponsored by VA Office of Research and Development.
NCT07356492 is a NA study of Health and Connectedness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 2,700 participants, roughly in line with the 2,837-participant average among 6 other Health trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07356492, a NA study of Health and Connectedness, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,700 participants
- Enrollment target
- 1
- Study location
Study Summary
Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration challenges during this transition are closely linked to increased suicide risk. The Veteran Sponsorship Initiative (VSI) was developed to address this critical period by connecting Transitioning Servicemembers and Veterans (TSMVs) with trained, VA-certified peer sponsors. These sponsors help TSMVs navigate civilian life and access VA care. Early evaluations show that TSMVs matched with sponsors are more likely to report lower levels of reintegration difficulties, higher levels of social support, engage in VA services and report lower rates of depression and suicide risk. This project enhances VSI by integrating predictive analytics-developed in partnership with Harvard Medical School and the DoW STARRS-LS team-to identify high-risk TSMVs before they leave the military. Those identified receive not only a sponsor but also targeted VA mental and health care services. This hybrid effectiveness-implementation study will evaluate the impact of this enhanced model (VSI+) on mental health outcomes and VA engagement among 2,700 high-risk TSMVs. Method/Design The purpose of this PEI proposal is to evaluate VSI expansion into VSI+ with enrollment occurring on four US Army installations (FY2026-2027). The study employs a pragmatic cluster-randomized trial with embedded mixed-method implementation evaluation to compare three arms: 1. Transition as Usual (TAU) 2. VSI Base= peer sponsorship and community support 3. VSI+= VSI Base plus VA stepped care services The evaluation is guided by the RE-AIM framework to assess: * Reach (enrollment rates) * Effectiveness (reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes) * Adoption (s
Primary Outcome
Reintegration difficulties will be assessed using the Military to Civilian Questionnaire (Primary Outcome; M2C-Q; Sayer et al., 2011), a 16-item measure that assesses reintegration difficulties in (a) interpersonal relationships with family, friends, and peers; (b) productivity at work, in school, or at home, (c) community participation; (d) self-care; (e) leisure, and (f) perceived meaning in life. Items are rated on a 5-point Likert scale ranging from 0 (No difficulty) to 4 (Extreme difficulty
Conditions Studied
Interventions
- BEHAVIORAL Onward Ops- receive peer sponsor and community support
- BEHAVIORAL VA stepped care services
Study Locations (1)
New York
- James J. Peters VA Medical Center, Bronx, NY - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT07356492 shows while recruiting
NCT07356492 is an interventional study that assigns participants to a tested intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,837-participant average among 6 other Health trials with a reported enrollment target.
The record links to 4 conditions, with Health appearing as the primary indexed condition, and to 2 interventions - of which Onward Ops- receive peer sponsor and community support is the first listed.
NCT07356492 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07356492 about?
NCT07356492 is a clinical study titled "Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach". Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration ...
What is the current status of trial NCT07356492?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,700 participants. The study started on 2026-01-01. Estimated completion is 2027-09-30.
What conditions does trial NCT07356492 study?
This clinical trial studies the following conditions: Health, Connectedness, Reintegration Difficulties, Suicidal Ideation and Behaviors.
What interventions are being tested in trial NCT07356492?
The interventions under investigation include: Onward Ops- receive peer sponsor and community support (BEHAVIORAL), VA stepped care services (BEHAVIORAL).
Who is sponsoring clinical trial NCT07356492?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07356492 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
National Sponsorship Program for Transitioning Service Members
RECRUITING · NA
-
Nutrition for Precision Health, Powered by the All of Us
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period
ACTIVE NOT RECRUITING · NA
-
Basic Income Guaranteed: Los Angeles Economic Assistance Pilot
COMPLETED · NA
-
Temporal Investigation of Multimodal Elements
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI